Prostate screening at The Holly Hospital

At present, there is no definitive test to screen for prostate cancer but PSA (Prostate Specific Antigen) is a protein that is only produced by the prostate gland to keep semen in a liquid form. Levels of PSA can be affected by several factors including prostate problems and at The Holly we offer PCA3 screening to assess your risk of prostate cancer.

What happens during the screen?

PCA3 screening is a new urine test that uses a form of DNA testing to measure the likelihood of developing prostate cancer. The screen is performed by a Consultant Urologist and consists of a digital rectal examination, a prostate or lower urinary tract assessment and analysis of a blood sample to check PSA levels and urine for PCA3. Your results will be available approximately ten days after your consultation.

Can I be screened for prostate cancer?

Prostate cancer screening is only carried out if deemed appropriate by the Consultant Urologist. If you would like to be screened you should seek advice from a Consultant Urologist first.

Those who may be suitable are men between the ages of 40 and 75, or men with an increased risk of prostate cancer including an African Caribbean background, a family history of prostate cancer and a diet high in saturated animal fats and red meat.